Novel substituted 2,3-benzodiazepine derivatives

Details for Australian Patent Application No. 2004208825 (hide)

Owner Ivax Institute for Drug Research, Ltd.

Inventors Andrasi, Ferenc; Berzsenyi, Pal; Hamori, Tamas; Kurucz, Istvan; Solyom, Sandor; Abraham, Gizella

Agent Griffith Hack

Pub. Number AU-A-2004208825

PCT Pub. Number WO2004/069197

Priority 10/358,053 04.02.03 US

Filing date 3 February 2004

Wipo publication date 19 August 2004

International Classifications

C07D 243/02 Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

Event Publications

11 August 2005 PCT application entered the National Phase

  PCT publication WO2004/069197 Priority application(s): WO2004/069197

7 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004208827-Sugar-free oral transmucosal solid dosage forms and uses thereof

2004208824-Novel compounds